Upcoming Webinars

Past Webinars

Future of Prostate Cancer Radiation Therapy


March 16, 2022


The Virtual Clinical Data Event will be hosted by the ViewRay leadership team and will feature the clinical work of Amar Kishan, MD., Associate Professor and Chief of the Genitourinary Oncology Service at UCLA. The event will feature a fireside chat between Dr. Kishan and Dr. Himanshu Nagar, MD, radiation oncologist Assistant Professor, Weill Cornell Medicine, New York-Presbyterian regarding the MIRAGE and SCIMITAR clinical trials and the future of prostate cancer radiation therapy.

March 16, 2022

4 pm EST

ASTRO 2021

Chicago, IL

October 24, 2021

Did you miss us at ASTRO… No problem, view our in-booth presentations on demand.

MR Guided Central and Ulta-Central Lung SBRT: Lung SBRT Introduction and WorkflowDr. Rupesh Kotecha, MCI & Dr. Stephen Rosenberg, Moffitt Cancer Center

MRIdian Solutions for Prostate Cancer  – Dr. Amar Kishan, UCLA

MRIdian Solutions for Breast CancerRyan Pennell, New York-Presbyterian/Weill Cornell Medicine

Expanding Your MRIdian Program to Multiple SystemsDr. Jennifer Dolan, Henry Ford Health System

Single Fraction Oligomets with MRIdian  – Dr. Michael Chuong, Miami Cancer Institute

MRIdian Solutions for Liver CancerDr. Michael Bassetti, University Wisconsin

MRIdian Solutions for Pancreas CancerDr. Jessica Frakes, Moffitt Cancer Center

MRIdian Solutions for Brain and use of Diffusion-Weighted Imaging (DWI)Dr. Eric Mellon, University of Miami

MRIdian Solutions for Oligometastatic CancerDr. Lauren Henke, Washington University


Delivering Strategic and Economic Value with MRI-Guided Radiation Therapy


June 24, 2021


Listen to this unique opportunity to learn how MRI-guided radiation therapy programs can deliver clinical benefit and how that can translate into strategic and economic value, based on a given center’s practice environment. Hear executive leadership, from two renowned institutions, share their insights into the decision-making factors that led to the investment in MRI-guided radiotherapy. Describing their experience, these executives will share the value MRI-guided radiotherapy brings to their cancer programs. They will discuss the clinical value to their patient care and how this unique technology has changed the types of cancers they treat and how it has added incremental benefits to their overall cancer care.

Physician Panel:

  • Daphne Haas-Kogan, MD, FASTRO
  • Gerard P. Walsh, MBA
  • Minesh Mehta, MD
  • Steven Holan, MBA

Moderated by Parashar Patel

Watch now

RSS Webinar: Techniques and Results of Ablative Radiation Doses for Inoperable Pancreas Cancer


May 13, 2021

11 am MDT

Webinar Description:
Prospective evidence demonstrates that non-ablative radiation dose improves local control without a meaningful impact on overall survival for patients with inoperable pancreas cancer. While the prescribed dose has historically been constrained due nearby GI organs at risk, the development of advanced treatment techniques has enabled the safe delivery of ablative hypofractionated radiation therapy. Emerging evidence suggests that dose intensification in selected patients achieves significantly improved long-term local control and overall survival.
After the webinar one should be able to:
• Describe challenges in ablative dose delivery for inoperable pancreas cancer
• Describe image guidance, motion management, and delivery techniques that enable ablative dose prescription for inoperable pancreas cancer
• Describe clinical outcomes of non-ablative versus ablative radiation therapy for inoperable pancreas cancer
Michael Chuong, MD, Miami Cancer Institute
Ann Raldow, MD, UCLA John Ng, MD, Weill Cornell Medicine
Chris Crane, MD, Memorial Sloan Kettering Cancer Center
Moderated By: Michael Chuong, MD, Miami Cancer Institute
This webinar has been supported by an unrestricted grant from ViewRay. This event is under the directed supervision of AMEDCO and Sponsor has had no part in the planning or delivery process.

The Evolution of SBRT: Prostate & Lung


March 16, 2021

12:00 PM EST

Stereotactic body radiation therapy (SBRT) has evolved significantly since its inception in the early 90s – from the use of X-ray-based image guidance and fiducial tracking to the dawn of MRI-guidance for direct tumor targeting and on-table adaptation. Join us for a webinar featuring leading SBRT experts from New York-Presbyterian Hospital/Weill Cornell Medical Center and Miami Cancer Institute to learn about the latest technological advances and how they’re shaping clinical practice and improving patient outcomes, particularly in the treatment of prostate and lung cancer.

Watch now

Differentiating your oncology program: Impact of MRIdian in a New Market


February 25, 2021

11:00 AM EST

About This Webinar
Assuta Medical Centers, Ramat Hahayal, Israel, is paving the way to provide the next generation of radiation therapy to patients in the middle east. Learn how MRIdian differentiated their program, why they selected MRIdian, how they launched the new service line, insights to tips and tricks for installation and commission, and an in-depth look at their clinical application.

Conquering Pancreatic Cancer: Moffitt Cancer Center’s multidisciplinary, personalized, team approach


December 16, 2020

12:00 PM EST

Join the Moffit Cancer Center multidisciplinary oncology team to learn about its approach to treating pancreatic cancer together. Treating one of the deadliest diseases takes a unique approach. Moffitt takes a patient-centric, holistic approach toward cancer care. By networking across departments to leverage the latest technologies and therapies Moffitt’s team approach provides personalized medicine that offers new opportunities for conquering pancreatic cancer.

You’ll hear from:

Chair, Gastrointestinal Oncology – Dr. Jason Fleming, MD, FACS
♢About Moffitt
♢Moffitt’s philosophical approach, teamwork, collaboration, and decision making

Radiation Oncologist – Sara Hoffe, MD
♢Radiation options and how they work
♢Overview of MRIdian system (Patient Perspective) and why it is different and vital part of the therapy mix
♢Case study experience

Surgeon – Pamela Hodul, MD
♢Challenges of surgery, borderline resectable cases and options
♢Operating post-SBRT: what you need to know

Med Onc – DaeWon Kim, MD
♢Current standard of care and options when treating with MRgRT

Radiologist – James Costello the MD, PHD
♢Staging, tumor identification, and margin determination. Progression analysis post-treatment.

Cutting-Edge Care for Unresectable Renal Cell Cancer: MRIdian SMART


November 13, 2020

9:00 AM MT


What treatment options do you offer patients with unresectable renal cell cancer, a disease typically resistant to conventional radiotherapy?

Join Amsterdam University Medical Centers’ Dr. Anna Bruynzeel and Omar Bohoudi, as they share Amsterdam UMC’s advanced approach to radiotherapy for unresectable renal cell cancer (RCC), including breakthrough data on 36 patients with primary RCC treated with 40 Gy/5 fractions using daily adaptive MRIdian SMART.


Anna Bruynzeel, MD, PhD, Radiation Oncologist
Omar Bohoudi, PhD Candidate, Dosimetrist and Radiation Therapist

Pancreatic Cancer in 2020: Surgery and Radiotherapy at the Cutting Edge


September 16, 2020

6:00 PM GMT | 11 AM MT

Join us for a multi-disciplinary, multi-institutional webinar uniting some of the best and brightest minds in pancreatic cancer care from the U.S. and U.K. We’ll hear from experts committed to advancing care, offering new treatment options, extending life, and improving quality of life for patients and their families battling this deadly disease.



Staging Pancreas Cancer: A Surgeon’s Perspective
Dr. Keith Roberts, HPB Surgeon, University of Birmingham School of Cancer Sciences, will share an overview of cutting-edge surgical options for pancreas cancer, including a look at borderline resectable cases and the role of radiation in treating these patients


The U.S. Experience Treating Pancreas Cancer on MRIdian
Dr. Michael Bassetti, University of Wisconsin Hospital and Clinics, will share his expertise in SBRT treatment for patients with unresectable disease.


University of Oxford/GenesisCare Compassionate Access Program
Dr. James Good, GenesisCare, will share an overview of their MRIdian SBRT program as well as their groundbreaking collaboration to provide MRIdian treatment at no cost to eligible NHS pancreatic cancer patients who otherwise would not receive treatment. Includes a case review.


MRIdian Vision Presentation
Dr. James F. Dempsey, ViewRay Inc., will share his vision of MRgRT technology and MRIdian.

The Physicist’s Guide to Choosing an MR-Linac: MRgRT at UCLA


August 19, 2020

9:00 AM PT

MRgRT offers a new world of cancer care. So, come explore the MR-Linac landscape with a seasoned guide: Dan Low, PhD, Vice-Chair of Medical Physics in the Department of Radiation Oncology at UCLA. Dr. Low will boldly tackle controversial topics like low-field versus high-field; imaging for diagnostics versus therapy delivery; understanding what really matters with gradient systems and imaging sequences; the promise and practice of DWI; and much more – including a Q&A. The goal of this webinar is to arm you with the information you need to make a positive impact on your patients and your practice. Don’t miss out.

Dan Low, PhD, Vice-Chair of Medical Physics, Department of Radiation Oncology UCLA

Real-Time, On-Table Adaptive with MRIdian: System Overview and Workflow Demonstration


July 15, 2020

AAPM 2020 Presentation Now On Demand

Join us for a demonstration of the features and functionality that support real-time, on-table, adaptive radiation therapy on the MRIdian system. This presentation includes a demonstration of workflow for an adaptive pancreatic case using real-time tissue tracking and beam gating, as well as time for questions.


Brett Sloman, Product Sales Support Director, ViewRay

WEBINAR: Day One, All-Day Adaptive: Dana-Farber/Brigham and Women’s Cancer Center Maximizes Clinical Value of MRIdian


July 23, 2020

12:00 PM EST

How did the experts at Dana-Farber/Brigham and Women’s Cancer Center do it?

At a time when the challenges of providing safe treatment to cancer patients crippled the ability to offer care and reduced revenue industry-wide, this program (less than a year old) is on a current run rate to treat ~250 adaptive patients annually, operating at 125% capacity as compared to pre-COVID times, and helping to backstop volume and revenue loss in other areas of the clinic.

Come hear this cross-functional team discuss building, launching, and growing a stunningly successful on-table, adaptive MR-guided radiation therapy program. They’ll share perspectives from leadership on administrative topics, program building, and clinical experience on the toughest-to-treat patients from both medical and physics viewpoints, as well as their approach to patient recruitment. And they’ll still have time for your questions. Join us!



Daphne Haas-Kogan, MD, FASTRO, Chair of the Department of Radiation Oncology
Raymond Mak, MD, Associate Professor of Radiation Oncology
Christopher Williams, PhD, Instructor of Radiation Oncology
Gerard P. Walsh, MBA, Executive Director for Radiation Oncology

WEBINAR: AAPM 2020 Ask the Expert Dr. James Dempsey


July 15, 2020

12:30 PM EST

Save your hardest questions for Dr. Dempsey, who has dedicated his career to solving impossible problems, inventing ingenious technologies and leading the charge in the fight against cancer by revolutionizing radiation therapy for patients worldwide. Don’t miss the chance to catch up with Dr. Dempsey in this Q&A session on the last day of AAPM.


James F. Dempsey, PhD, Chief Science Officer, ViewRay

WEBINAR: AAPM 2020 Ask the Expert Indrin Chetty, PhD


July 14, 2020

12:30 PM ET

What questions do you have for the pioneers at Henry Ford, home of the world’s first MRIdian Linac? With three years of patient treatments under their belts, they are experts on establishing and growing a MRIdian program, creating enough demand from patients and referring physicians to require the installation of a second system. Join Dr. Chetty for this engaging, interactive session.



Indrin J. Chetty, PhD, Professor and Division Head of Medical Physics, Department of Radiation Oncology, Henry Ford Health System

WEBINAR: AAPM 2020 Ask the Expert: Christopher Williams, PhD


July 13, 2020

12:30 PM EST

Here’s your chance to ask the lead physicist from Brigham and Women’s Hospital anything you want to know about how to successfully launch a MRIdian program, from commissioning to adaptation on their first treatment. They’ve treated more than 100 patients on MRIdian in the first nine months, so now’s the time to get great tips and tricks from the experts in operational excellence.


Christopher Williams, PhD,
Chief of MR-Based Adaptive Treatment, Dana-Farber/Brigham and Women’s Cancer Center

WEBINAR: AAPM 2020 Ask the Expert: Maria Bellon and James Victoria


July 12, 2020

12:30 PM EST

Bring your questions to two of our best in-house experts in physics and treatment workflow and get the answers you need. This interactive discussion is designed to reveal tips and tricks for using MRIdian and MR guidance to advance patient care, so join Maria and Vito to discuss whatever is on your mind.



Maria Bellon, Manager Medical Physics RSO, ViewRay
James “Vito” Victoria, CMD, RT Scientist, ViewRay

WEBINAR: ‘One and Done’ Single Fraction: the Future of MR-Guided Lung Radiotherapy with Amsterdam UMC


June 24, 2020

10:00 AM ET

Safely treating lung tumors with ablative doses can be challenging, from central and ultra central to single fraction requires a new level of precision and accuracy. See how Amsterdam University Medical Center is using MRIdian to treat smarter with ablative doses that work harder to destroy tumors and spare healthy tissues. Join this webinar where they will share their experience treating lung cancer with single fraction SABR. With the potential to improve outcomes, reduce side effects and deliver better patient quality of life, is this the future of cancer care? Come see what you may be missing. 



Prof. Suresh Senan, MD, Professor of Clinical Experimental Radiotherapy

Miguel Palacios, PhD, Medical Physicist 

WEBINAR: Learnings from Los Angeles with UCLA Health – Ultra-Hypofractionation During the COVID-19 Pandemic


June 8, 2020

6:00 PM EST


Please join us to hear from the Radiation Oncology department at UCLA Health on the overall impact COVID-19 may have on the practice of radiation oncology therapy moving forward. Learn how their team is leveraging MRIdian and adapting patient care to offer fewer fractions and ablative doses, including a case study on prostate SBRT. Drs. Steinberg and Kishan will also offer an overview of their MRIdian program and topline the promising clinical trials underway at UCLA that have the potential to reshape patient treatment in the future


Dr. Michael Steinberg
, Professor and Chair, Department of Radiation Oncology
Dr. Amar Kishan, Assistant Professor

WEBINAR: GenesisCare – Implementing MRIdian SABR in the UK


June 3, 2020

1:00 PM EST


With cancer treatment centres in Australia, Spain, the United Kingdom and now the United States, GenesisCare is the world’s largest private provider of radiotherapy. Working in collaboration with the University of Oxford, GenesisCare has brought the UK’s first MRIdian MR-guided facility to the UK.


On this webinar, the team will be discussing the insights gained during the MRIdian implementation process and from treating their first 50 patients, leveraging MR-guided radiotherapy and adapting patient care to a rapidly changing cancer landscape. Hear about the role of SABR as an alternative to surgery and chemotherapy for urological and hepatobiliary cancers, and in the setting of reirradiation.



Dr. James Good, Clinical Director of SBRT

Dr. Philip Camilleri, Clinical Director of Urology

Dr. Veni Ezhil, Specialist SBRT Advisor

WEBINAR: Treating Cancer in Turkey: Acibadem RT with MRIdian SBRT


May 13, 2020

10:00 AM EST

Please join us to hear how the radiation oncology team at Turkey’s Acibadem Maslak Hospital adapted patient care and departmental procedures amidst COVID-19, leveraging MRIdian to offer fewer fractions and ablative doses in a time when surgery and chemo are not available to all. Learn about the advantages of SBRT and MRIdian during a crisis and how this may reshape the future of cancer care in a rapidly changing cancer care landscape. 



Dr. Enis Ozyar, Professor of Radiation Oncology

Dr. Banu Atalar, Professor of Radiation Oncology

Gorkem Gungor, Senior Medical Physics Expert 

WEBINAR: Expertise from Italy’s Frontline: Cancer Care, MRIdian & COVID-19


May 6, 2020

11:45 AM EST

How did Italy’s frontline, Gemelli ART, respond to the COVID-19 pandemic? Hear how they adapted patient care and departmental procedures in radiation oncology to reduce patient encounters with the hospital system, leveragingMRIdian to offer fewer fractions and ablative doses in a time when surgery and chemo were not available to all. Learn how SBRT and MRIdian are reshaping the future of cancer care in a rapidly changing cancer care landscape. 



Luca Boldrini, MD; Medical Director, Radiation Oncologist

Davide Cusumano, PhD; Medical Physicist



April 22, 2020

Join us on Wednesday, April 22 at 4 PM EST as we learn how Miami Cancer Institute, Baptist Health South Florida has adapted patient care and departmental procedures during the COVID-19 pandemic, with a special focus on the role of radiation oncology and SBRT during this time of crisis. We’ll discuss best practices, swap ideas and plan together for the future.



Dr. Minesh Mehta, Deputy Director, Chief of Radiation Oncology

Dr. Michael Chuong, Director of MR-Guided Radiation Therapy and Proton Therapy

Alonso Gutierrez, Chief of Medical Physics

(Webinar) Treating Tumors that Move: The Promise and Practice of Real-time MR Image Guidance During Radiation Beam Delivery


September 20, 2018

Learn about MRI-Guided RT technology as it relates to managing tumor motion and delivering precise radiation therapy. Speakers from NewYork-Presbyterian Hospital / Weill Cornell Medicine and University of Wisconsin-Madison share their clinical experience with continuous, high-quality soft tissue visualization and automated beam-gating on MRIdian.

Watch the recorded webinar by registering on Imaging Technology News (ITN).


  Global Info


Please log in to access the ViewRay Customer Portal. To request access, please click here. Request will be reviewed within 2 business days.

Existing Users Log In

This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of our products and services, assist with our promotional and marketing efforts, and provide content from third parties. Cookie Policy